Dyne Therapeutics, Inc. ($DYN)
Filing Information
| Accession Number | 0001577014-26-000014 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 8, 2026 |
| Document | View SEC Filing |
Transactions
10
Total Shares
777,451
Total Value
$17,858,491.67
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jul 6, 2026 | Sale | 253,039 | $22.79 | $5,766,758.81 | 4,223,448 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jul 6, 2026 | Sale | 127,182 | $22.79 | $2,898,477.78 | 1,217,537 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jul 6, 2026 | Sale | 100,019 | $22.79 | $2,279,433.01 | 875,912 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jul 7, 2026 | Sale | 124,379 | $23.17 | $2,881,861.43 | 4,099,069 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jul 7, 2026 | Sale | 29,587 | $23.62 | $698,844.94 | 4,069,482 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jul 7, 2026 | Sale | 62,543 | $23.17 | $1,449,121.31 | 1,154,994 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jul 7, 2026 | Sale | 14,844 | $23.62 | $350,615.28 | 1,140,150 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jul 7, 2026 | Sale | 49,193 | $23.17 | $1,139,801.81 | 826,719 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jul 7, 2026 | Sale | 11,665 | $23.62 | $275,527.30 | 815,054 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jul 7, 2026 | Sale | 5,000 | $23.61 | $118,050.00 | 2,962 | Indirect | See footnote | View Details |